NDC 54092-701
Vpriv 2.5 mg per 1 mL injection, powder, lyophilized, for solution
On the label: Takeda Pharmaceuticals America, Inc..
Where it's made
This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Takeda Pharmaceuticals America, Inc. names for other drugs.
Recalls
- Mar 14, 2014 · Class I · Shire Human Genetic Therapies, Inc.
Presence of Particulate Matter; Particulates identified as stainless steel and barium sulfate.
Lots: US: Lot #: FEW13-001, FEW13-002, FED13-006; Expiry: 10/15. Mexico: Lot #: FED 013-010; Expiry: 10/15. Columbia: Lot #: FED 013-011; Expiry: 10/15.
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Velaglucerase Alfa: every company that makes it
- Form
- injection, powder, lyophilized, for solution, intravenous
- Strength
- 2.5 mg per 1 mL
- Approval
- BLA BLA022575
- On the market since
- Feb 26, 2010
- Package NDCs
54092-701-04- Official label
- DailyMed (National Library of Medicine), updated Nov 26, 2024
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?